Breast Cancer
News
Omega-3 fatty acids similar to placebo for aromatase inhibitor–induced musculoskeletal pain
Key clinical point: Patients who received omega-3 fatty acid (O3-FA) capsules, as well as those who received placebo, had significant, sustained...
Conference Coverage
AACR: Targeted combo active in triple-negative breast cancer, ovarian cancer
Key clinical point: Combining the PARP inhibitor olaparib and the investigational P13K inhibitor BKM 120 is safe and active in triple-negative...
David Henry's JCSO Podcast
David Henry's JCSO podcast, April 2015
News
Exercise pumps up chemotherapy completion rates for breast cancer patients
Key clinical point: Moderate- to high-intensity exercise during adjuvant chemotherapy improves completion rates.
News
Contamination prompts voluntary injectables recall
News
Oophorectomy improves survival after breast cancer in BRCA1 carriers
Key clinical point: Oophorectomy significantly improved the prognosis of women with breast cancer and a BRCA1 mutation. Major finding: The...
Original Report
Feasibility of implementing a community-based randomized trial of yoga for women undergoing chemotherapy for breast cancer
Community Translations
Palonosetron and netupitant for prevention of chemotherapy-induced nausea and vomiting
From the Editor
Managing change in oncology
News
PD-L1 blockade breaks through triple-negative breast cancer
Key clinical point: The investigative anti-PD-L1 immunotherapy MPDL3280A was clinically active and generally well tolerated in metastatic triple-...